Han‐Jik Ko

Statistics

Publications

Citations

H-Index

Active since

2015

Affiliations

Osong Medical Innovation Foundation(Current)

Han‐Jik Ko is an author at Osong Medical Innovation Foundation specializing in pharmacology, monoclonal antibodies in oncology, and antibody-drug conjugates.

ORCID

Publications per year

2015–2021

Publications

N-trans-ρ-caffeoyl tyramine isolated from Tribulus terrestris exerts anti-inflammatory effects in lipopolysaccharide-stimulated RAW 264.7 cells

Han‐Jik Ko, Eun‐Kyung Ahn, Joa Sub Oh · International Journal of Molecular Medicine · 2015 · 34 citations · Full text

Life Sciences, Immunology, Pharmacology +17

A novel anti‐c‐Kit antibody–drug conjugate to treat wild‐type and activating‐mutant c‐Kit‐positive tumors

Jin‐Ock Kim, Kwang‐Hyeok Kim, Eun Ji Baek et al. · Molecular Oncology · 2021 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

1–2 of 2